Emerging role of Akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications von Zdychová, J, Komers, R

Volltext

Potential of Seaweed Gracilaria sp. As inhibitors of Escherichia coli, Clostridium perfringens and Stapylococcus aureus von Kaimudin, Marni, Manduapessy, Komers R.W., Sumarsana

Volltext

Determination of caveolin-1 in renal caveolar and non-caveolar fractions in experimental type 1 diabetes von Demová, H, Komers, R

Volltext

Thiazolidinediones--tools for the research of metabolic syndrome X von Komers, R, Vrána, A

Volltext

Renal activity of Akt kinase in experimental Type 1 diabetes von Ždychová, J, Veselá, J, Kazdová, L, Komers, R

Volltext

A Polymorphism in the Cyclooxygenase 2 Gene in Type 1 Diabetic Patients With Nephropathy von HUBÁČEK, J. A., PELIKÁNOVÁ, T., LÁNSKÁ, V., KOMERS, R.

Volltext

Paradoxes of nitric oxide in the diabetic kidney von Komers, Radko, Anderson, Sharon

Volltext

WCN23-1087 SPARSENTAN REDUCES PROTEINURIA IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IGAN): INTERIM RESULTS OF THE PROTECT STUDY von Wong, M.G., Heerspink, H.J., Komers, R., Mercer, A., Radhakrishnan, J.

Volltext

WCN23-1184 LONG-TERM EFFICACY AND SAFETY OF SPARSENTAN IN YOUNG PATIENTS WITH FSGS: 240-WEEK ANALYSIS OF THE DUET OPEN-LABEL EXTENSION (OLE) von LIEBERMAN, K., Paredes, A., Srivastava, T., Komers, R., Murphy, E., Trachtman, H.

Volltext

Acute renal hemodynamic effects of ACE inhibition in diabetic hyperfiltration: role of kinins von Komers, R, Cooper, M. E

Volltext

SUN-037 NO IMPACT OF NEWLY INITIATED IMMUNOSUPPRESSIVE THERAPY OBSERVED ON LONG-TERM ANTIPROTEINURIC EFFECT OF SPARSENTAN IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS: INTERIM 84-WEEK ANA... von Tesar, V., Trachtman, H., Murphy, E., Ferguson, B., Komers, R.

Volltext

Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes von Komers, R, Lindsley, J N, Oyama, T T, Schutzer, W E, Reed, J F, Mader, S L, Anderson, S

Volltext

Therapeutic potential of ACE inhibitors for the treatment of hypertension in Type 2 diabetes von Komers, Radko, Komersova, Karla

Volltext

Treatment of hypertension in diabetic patients with nephropathy von Komers, R, Anderson, S

Volltext

Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors von Komers, Radko, Anderson, Sharon, Epstein, Murray

Volltext

G12 Effect of hyperinsulinemia on renal excretory function and excretion of nitric oxide (NO) metabolites in healthy subjects von Komers, R., Pelikánová, T., Kazdová, L.

Volltext

Renal cyclooxygenase-2 in obese Zucker (fatty) rats von Komers, Radko, Zdychova, Jana, Cahova, Monika, Kazdova, Ludmila, Lindsley, Jessie N., Anderson, Sharon

Volltext

Role of neuronal nitric oxide synthase (NOS1) in the pathogenesis of renal hemodynamic changes in diabetes von Komers, R, Lindsley, J N, Oyama, T T, Allison, K M, Anderson, S

Volltext

Sparsentan Dual angiotensin II AT(1) receptor blocker and endothelin ETA receptor antagonist Treatment of focal segmental glomerulosclerosis Treatment of IgA nephropathy von Trachtman, H., Hogan, J. J., Tesar, Komers, R.

Volltext

Endothelial-derived vasoactive mediators in polycystic kidney disease von Al-Nimri, Muna A., Komers, Radko, Oyama, Terry T., Subramanya, Arohan R., Lindsley, Jessie N., Anderson, Sharon

Volltext